Comparative bioavailability of two fluconazole capsule formulations in healthy volunteers

Arzneimittel-Forschung/Drug Research

Volumn 50, Issue 11, 2000, Pages 1028-1032

  Ribeiro, W ^a   Zappi, E A ^a   Moraes, M E A ^a   Bezerra, F A F ^a   Lerner, F E ^a   De Nucci, G ^a  

^a Jesuino Marcondes Machado   (Brazil)

Author keywords

Bioequivalence studies; CAS 86386 73 4; Fluconazole; Zoltrix

Indexed keywords

FLUCONAZOLE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; FEMALE; FOOD AND DRUG ADMINISTRATION; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL;

EID: 0033711404     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1300328     Document Type: Article

References (14)

1. Clinical pharmacokinetic of tramadol
2. Drug interactions with fluconazole
3. Introduction of fluconazole metabolism by rifampin - In vivo study in humans
4. Fluconazole bioequivalence study: Quantification by tandem mass spectrometry
5. An analytic aproximation to the distribution of liliefors test statistics for normality
6. Food and Drug Administration
7. Current practice of BA/BE requirements for immediate release products in EU
8. Bioequivalence - An updated reappraisal adressed to applications of interchangeable multisource pharmaceutical products
9. Design for group sequential-tests
10. Fluoxetine bioequivalence study: Quantification of fluoxetine and norfluoxetine by liquid chromatography coupled to mass spectrometry
11. Comparative bioavailability of two sertraline tablets formulations in healthy human volunteers after a single dose administration